|
1
|
Ehrmann DA: Polycystic ovary syndrome. N
Engl J Med. 352:1223–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dunaif A and Thomas A: Current concepts in
the polycystic ovary syndrome. Annu Rev Med. 52:401–419. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boulman N, Levy Y, Leiba R, Shachar S,
Linn R, Zinder O and Blumenfeld Z: Increased C-reactive protein
levels in the polycystic ovary syndrome: a marker of cardiovascular
disease. J Clin Endocrinol Metab. 89:2160–2165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kelly CC, Lyall H, Petrie JR, Gould GW,
Connell JM and Sattar N: Low grade chronic inflammation in women
with polycystic ovarian syndrome. J Clin Endocrinol Metab.
86:2453–2455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vgontzas AN, Trakada G, Bixler EO, Lin HM,
Pejovic S, Zoumakis E, Chrousos GP and Legro RS: Plasma interleukin
6 levels are elevated in polycystic ovary syndrome independently of
obesity or sleep apnea. Metabolism. 55:1076–1082. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hotamisligil GS, Peraldi P, Budavari A,
Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of
insulin receptor tyrosine kinase activity in TNF-alpha- and
obesity-induced insulin resistance. Science. 271:665–668. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun Q, Li L, Li R, et al: Overexpression
of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and
lipid profile in rats. Ann Med. 41:311–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukuhara A, Matsuda M, Nishizawa M, et al:
Visfatin: a protein secreted by visceral fat that mimics the
effects of insulin. Science. 307:426–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carmina E, Bucchieri S, Mansueto P, Rini
G, Ferin M and Lobo RA: Circulating levels of adipose products and
differences in fat distribution in the ovulatory and anovulatory
phenotypes of polycystic ovary syndrome. Fertil Steril. 91(4
Suppl): 1332–1335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cekmez F, Cekmez Y, Pirgon O, Canpolat FE,
Aydinöz S, Metin Ipcioglu O and Karademir F: Evaluation of new
adipocytokines and insulin resistance in adolescents with
polycystic ovary syndrome. Eur Cytokine Netw. 22:32–37.
2011.PubMed/NCBI
|
|
12
|
Gen R, Akbay E, Muslu N, Sezer K and Cayan
F: Plasma visfatin level in lean women with PCOS: relation to
proinflammatory markers and insulin resistance. Gynecol Endocrinol.
25:241–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jongwutiwes T, Lertvikool S, Leelaphiwat
S, Rattanasiri S, Jultanmas R and Weerakiet S: Serum visfatin in
Asian women with polycystic ovary syndrome. Gynecol Endocrinol.
25:536–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kowalska I, Straczkowski M, Nikolajuk A,
et al: Serum visfatin in relation to insulin resistance and markers
of hyperandrogenism in lean and obese women with polycystic ovary
syndrome. Hum Reprod. 22:1824–1829. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ozkaya M, Cakal E, Ustun Y and Engin-Ustun
Y: Effect of metformin on serum visfatin levels in patients with
polycystic ovary syndrome. Fertil Steril. 93:880–884. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Plati E, Kouskouni E, Malamitsi-Puchner A,
Boutsikou M, Kaparos G and Baka S: Visfatin and leptin levels in
women with polycystic ovaries undergoing ovarian stimulation.
Fertil Steril. 94:1451–1456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan BK, Chen J, Digby JE, Keay SD, Kennedy
CR and Randeva HS: Increased visfatin messenger ribonucleic acid
and protein levels in adipose tissue and adipocytes in women with
polycystic ovary syndrome: parallel increase in plasma visfatin. J
Clin Endocrinol Metab. 91:5022–5028. 2006. View Article : Google Scholar
|
|
18
|
Yildiz BO, Bozdag G, Otegen U, et al:
Visfatin and retinol-binding protein 4 concentrations in lean,
glucose-tolerant women with PCOS. Reprod Biomed Online. 20:150–155.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dikmen E, Tarkun I, Cantürk Z and
Cetinarslan B: Plasma visfatin level in women with polycystic ovary
syndrome. Gynecol Endocrinol. 27:475–479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lajunen TK, Purhonen AK, Haapea M, et al:
Full-length visfatin levels are associated with inflammation in
women with polycystic ovary syndrome. Eur J Clin Invest.
42:321–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tarkun I, Dikmen E, Cetinarslan B and
Cantürk Z: Impact of treatment with metformin on adipokines in
patients with polycystic ovary syndrome. Eur Cytokine Netw.
21:272–277. 2010.PubMed/NCBI
|
|
22
|
Zwirska-Korczala K, Sodowski K, Konturek
SJ, et al: Postprandial response of ghrelin and PYY and indices of
low-grade chronic inflammation in lean young women with polycystic
ovary syndrome. J Physiol Pharmacol. 59(Suppl 2): 161–178.
2008.PubMed/NCBI
|
|
23
|
Chan TF, Chen YL, Chen HH, Lee CH, Jong SB
and Tsai EM: Increased plasma visfatin concentrations in women with
polycystic ovary syndrome. Fertil Steril. 88:401–405. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsiotra PC, Tsigos C, Yfanti E, et al:
Visfatin, TNF-alpha and IL-6 mRNA expression is increased in
mononuclear cells from type 2 diabetic women. Horm Metab Res.
39:758–763. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seow KM, Hwang JL, Wang PH, Ho LT and Juan
CC: Expression of visfatin mRNA in peripheral blood mononuclear
cells is not correlated with visfatin mRNA in omental adipose
tissue in women with polycystic ovary syndrome. Hum Reprod.
26:2869–2873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng KH, Xue M and Xiao SS: mRNA
expression of visfatin in omentaladipose tissue in polycystic ovary
syndrome. Xian Dai Sheng Wu Yi Xue Jin Zhan. 13:2514–2516.
25372009.(In Chinese).
|
|
27
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group. Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
|
|
28
|
Chen X, Yang D, Li L, Feng S and Wang L:
Abnormal glucose tolerance in Chinese women with polycystic ovary
syndrome. Hum Reprod. 21:2027–2032. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Curat CA, Wegner V, Sengenès C, Miranville
A, Tonus C, Busse R and Bouloumié A: Macrophages in human visceral
adipose tissue: increased accumulation in obesity and a source of
resistin and visfatin. Diabetologia. 49:744–747. 2006.PubMed/NCBI
|
